Daisuke Fujisawa
Representative, Japan
ACBTA / Asia
Daisuke Fujisawa, MD, PhD, is a psychiatrist, cognitive behavioural therapist, and researcher based in Tokyo, Japan. He is Chief of the Division of Quality Assurance Programs at the National Cancer Center Japan Institute for Cancer Control and an Adjunct Professor at Keio University School of Medicine, where he completed his medical and doctoral training.
Dr. Fujisawa is President of the Japanese Association for Cognitive Therapy and President-Elect of the Asian Cognitive Behavioral Therapies Association. He represents the ACBTA on the Board of the World Confederation of Cognitive and Behavioural Therapies. He also serves as the Asia-Pacific Director of the International Psycho-Oncology Society. He is a qualified CBT supervisor under the training programme of Japan’s Ministry of Health, Labour and Welfare, and an International Diplomate member of the Academy of Cognitive and Behavioral Therapies, through which he is certified as a therapist and rater.
His clinical and research interests include cognitive behavioural therapy, mindfulness-based interventions, psycho-oncology, geriatric psychiatry, and consultation-liaison psychiatry. Much of his work has focused on improving the psychological care of people affected by cancer, including interventions addressing emotional distress, cancer-related stigma, grief, illness understanding, and quality of life. He has also contributed to clinical guidelines, therapist training, and research on the effective delivery and wider dissemination of CBT in Japan. Through his clinical, academic, and professional leadership, Dr. Fujisawa has supported the continued development of evidence-based psychological therapies across Japan and the wider Asian region.